AACR: mRNA-4157 Plus Pembrolizumab Beneficial in Melanoma
Combination of mRNA vaccine and pembrolizumab significantly prolongs recurrence-free survival versus pembrolizumab alone
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.